<code id='5B1361FD3C'></code><style id='5B1361FD3C'></style>
    • <acronym id='5B1361FD3C'></acronym>
      <center id='5B1361FD3C'><center id='5B1361FD3C'><tfoot id='5B1361FD3C'></tfoot></center><abbr id='5B1361FD3C'><dir id='5B1361FD3C'><tfoot id='5B1361FD3C'></tfoot><noframes id='5B1361FD3C'>

    • <optgroup id='5B1361FD3C'><strike id='5B1361FD3C'><sup id='5B1361FD3C'></sup></strike><code id='5B1361FD3C'></code></optgroup>
        1. <b id='5B1361FD3C'><label id='5B1361FD3C'><select id='5B1361FD3C'><dt id='5B1361FD3C'><span id='5B1361FD3C'></span></dt></select></label></b><u id='5B1361FD3C'></u>
          <i id='5B1361FD3C'><strike id='5B1361FD3C'><tt id='5B1361FD3C'><pre id='5B1361FD3C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:53
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Ebola: Gilead Sciences antiviral shows promise as new treatment
          Ebola: Gilead Sciences antiviral shows promise as new treatment

          UgandamedicalstaffatanEbolatreatmentcenterinthetownofMubende.BADRUKATUMBA/AFPviaGettyImagesAnewstudy

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand